Clinical Trial Update: Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2

View source ↗

Summary

A prospective evaluation of an AI-based patient stratification tool for renal immuno-oncology in metastatic renal cell carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Ourotech, Inc. | Conditions: Kidney Cancer, Renal Cell Cancer Metastatic | Status: TERMINATED